BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16246327)

  • 1. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
    Visser GD; Lill NL
    Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.
    Lill NL; Douillard P; Awwad RA; Ota S; Lupher ML; Miyake S; Meissner-Lula N; Hsu VW; Band H
    J Biol Chem; 2000 Jan; 275(1):367-77. PubMed ID: 10617627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ubiquitination of EGF receptors with C-terminal domain deletion and point mutations during endocytosis].
    Kondratov KA; Melikova MS; Chernorudskiĭ AL; Kornilova ES
    Tsitologiia; 2009; 51(7):617-23. PubMed ID: 19764654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.
    Thien CB; Langdon WY
    Oncogene; 1997 May; 14(18):2239-49. PubMed ID: 9174060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor fate is controlled by Hrs tyrosine phosphorylation sites that regulate Hrs degradation.
    Stern KA; Visser Smit GD; Place TL; Winistorfer S; Piper RC; Lill NL
    Mol Cell Biol; 2007 Feb; 27(3):888-98. PubMed ID: 17101784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor.
    Oksvold MP; Thien CB; Widerberg J; Chantry A; Huitfeldt HS; Langdon WY
    Oncogene; 2003 Nov; 22(52):8509-18. PubMed ID: 14627991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain.
    Sun Q; Jackson RA; Ng C; Guy GR; Sivaraman J
    PLoS One; 2010 Sep; 5(9):e12819. PubMed ID: 20877636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl.
    Thien CB; Langdon WY
    Oncogene; 1997 Dec; 15(24):2909-19. PubMed ID: 9416834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate.
    Stern KA; Place TL; Lill NL
    Biochem J; 2008 Mar; 410(3):585-94. PubMed ID: 18045238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation.
    Yoon CH; Chang C; Hopper NA; Lesa GM; Sternberg PW
    Mol Biol Cell; 2000 Nov; 11(11):4019-31. PubMed ID: 11071924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spred-2 steady-state levels are regulated by phosphorylation and Cbl-mediated ubiquitination.
    Lock P; I ST; Straffon AF; Schieb H; Hovens CM; Stylli SS
    Biochem Biophys Res Commun; 2006 Dec; 351(4):1018-23. PubMed ID: 17094949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor.
    Smith CJ; Berry DM; McGlade CJ
    J Cell Sci; 2013 Mar; 126(Pt 6):1366-80. PubMed ID: 23418353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.
    Haglund K; Schmidt MHH; Wong ES; Guy GR; Dikic I
    EMBO Rep; 2005 Jul; 6(7):635-41. PubMed ID: 15962011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation.
    Grøvdal LM; Stang E; Sorkin A; Madshus IH
    Exp Cell Res; 2004 Nov; 300(2):388-95. PubMed ID: 15475003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor.
    Meisner H; Czech MP
    J Biol Chem; 1995 Oct; 270(43):25332-5. PubMed ID: 7592693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces.
    Liang Y; Kurakin A; Roizman B
    Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5838-43. PubMed ID: 15824310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function.
    Fong CW; Leong HF; Wong ES; Lim J; Yusoff P; Guy GR
    J Biol Chem; 2003 Aug; 278(35):33456-64. PubMed ID: 12815057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase.
    Ota S; Hazeki K; Rao N; Lupher ML; Andoniou CE; Druker B; Band H
    J Biol Chem; 2000 Jan; 275(1):414-22. PubMed ID: 10617633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.